Name: Latest research reports of Marksans Pharma Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Marksans Pharma Ltd.
Rating: 5
Author: Axis Direct

Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer

314.1500 -3.10 (-0.98%)

NSE Oct 14, 2026 15:31 PM

102.68% Gain from 52W Low

Volume: 592.3K

Marksans Pharma Ltd.

31 Aug 2026

314.15

-0.98%

Axis Punch:Marksans Pharma

Buy: Marksans Pharma Ltd.

Axis Direct

We recommend a BUY on the stock with a target price of Rs 362/share, implying an upside of 10% from the CMP.

Marksans Pharma has gained 78.35% in the last 6 Months